- Conditions
- Ependymoma, Medulloblastoma, Neuroblastoma (Measurable Disease), Neuroblastoma (Metaiodobenzylguanidine, Non-brainstem High-grade Glioma, Osteosarcoma, Positive Evaluable), Rhabdomyosarcoma, Sarcoma, Ewing's
- Interventions
- pemetrexed
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- Up to 22 Years
- Enrollment
- 72 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2010
- U.S. locations
- 1
- States / cities
- Arcadia, California
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–1
of 1
matching trial from the local directory fallback.
Local D1 index available.